First approval for new tuberculosis drugs paves the way for better combinations of new and old agents.

Tuberculosis remains a major cause of death worldwide. The rise and spread of drug resistance and synergistic interaction with the HIV epidemic are posing difficult challenges and threatening global efforts at tuberculosis control.

The document describes the early evidence on use of the tool – including research findings and modeling results – and provides algorithms for the management of people living with HIV and with presumptive TB.

Together with the website Take That TB, Treatment Action Group has created a listserv to connect TB and MDR-TB survivors and patients interested in conducting advocacy and connecting with others in this community.

The participants in a workshop convened last week by the World Health Organization (WHO) and the Stop TB Partnership have proposed a set of goals and targets to guide the global fight against TB after 2015.

Video presentations from the "Aspiring to Zero TB Deaths, New Infections, and Suffering" symposium held at the 2012 International Union Against TB and Lung Disease World Conference in Kuala Lumpur are now available online! 

Mario Raviglione, director of the WHO's Stop TB Department: “My aim is to reach a consensus right now. If we wait, we may miss the train.”

Vaccine candidate was generally well tolerated, meeting the study’s primary objective of safety; Vaccine candidate did not provide statistically-significant protection in preventing TB disease in infants previously vaccinated with BCG.

The Cochrane analysis represents the most comprehensive review on the diagnostic accuracy of Xpert and provides evidence that may help countries make decisions about scaling up Xpert for programmatic management of TB and drug-resistant TB.

By doing so, the bacteria take advantage of the body's own mechanisms of self-renewal.